PMC:7445716 / 28483-28748 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T113","span":{"begin":65,"end":69},"obj":"Body_part"},{"id":"T114","span":{"begin":218,"end":221},"obj":"Body_part"}],"attributes":[{"id":"A113","pred":"fma_id","subj":"T113","obj":"http://purl.org/sig/ont/fma/fma7182"},{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma20935"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T67","span":{"begin":65,"end":69},"obj":"Body_part"}],"attributes":[{"id":"A67","pred":"uberon_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/UBERON_0002101"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T314","span":{"begin":48,"end":63},"obj":"Disease"},{"id":"T315","span":{"begin":70,"end":76},"obj":"Disease"}],"attributes":[{"id":"A314","pred":"mondo_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/MONDO_0003425"},{"id":"A315","pred":"mondo_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":65,"end":69},"obj":"http://www.ebi.ac.uk/efo/EFO_0000876"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T109","span":{"begin":148,"end":150},"obj":"Chemical"},{"id":"T110","span":{"begin":151,"end":153},"obj":"Chemical"},{"id":"T111","span":{"begin":157,"end":159},"obj":"Chemical"},{"id":"T112","span":{"begin":204,"end":206},"obj":"Chemical"}],"attributes":[{"id":"A109","pred":"chebi_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A111","pred":"chebi_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-sentences","denotations":[{"id":"T162","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T343","span":{"begin":48,"end":63},"obj":"Phenotype"},{"id":"T344","span":{"begin":65,"end":76},"obj":"Phenotype"},{"id":"T345","span":{"begin":90,"end":99},"obj":"Phenotype"},{"id":"T346","span":{"begin":101,"end":109},"obj":"Phenotype"},{"id":"T347","span":{"begin":118,"end":130},"obj":"Phenotype"},{"id":"T348","span":{"begin":132,"end":147},"obj":"Phenotype"},{"id":"T349","span":{"begin":160,"end":165},"obj":"Phenotype"},{"id":"T350","span":{"begin":167,"end":172},"obj":"Phenotype"},{"id":"T351","span":{"begin":174,"end":181},"obj":"Phenotype"},{"id":"T352","span":{"begin":183,"end":191},"obj":"Phenotype"},{"id":"T353","span":{"begin":196,"end":203},"obj":"Phenotype"}],"attributes":[{"id":"A343","pred":"hp_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/HP_0000602"},{"id":"A344","pred":"hp_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/HP_0002070"},{"id":"A345","pred":"hp_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/HP_0001284"},{"id":"A346","pred":"hp_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/HP_0000651"},{"id":"A347","pred":"hp_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/HP_0003474"},{"id":"A348","pred":"hp_id","subj":"T348","obj":"http://purl.obolibrary.org/obo/HP_0030319"},{"id":"A349","pred":"hp_id","subj":"T349","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A350","pred":"hp_id","subj":"T350","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A351","pred":"hp_id","subj":"T351","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A352","pred":"hp_id","subj":"T352","obj":"http://purl.obolibrary.org/obo/HP_0004409"},{"id":"A353","pred":"hp_id","subj":"T353","obj":"http://purl.obolibrary.org/obo/HP_0041051"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T248","span":{"begin":65,"end":69},"obj":"UBERON:0002101"},{"id":"T249","span":{"begin":111,"end":117},"obj":"UBERON:0001456"},{"id":"T250","span":{"begin":132,"end":138},"obj":"UBERON:0001456"},{"id":"T251","span":{"begin":167,"end":172},"obj":"UBERON:0002048"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}

{"project":"2_test","denotations":[{"id":"32840686-32662899-63205723","span":{"begin":18,"end":20},"obj":"32662899"}],"text":"Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant"}